Skip to content
Home/Companies/Biotech/Gyroscope Therapeutics
GT

Gyroscope Therapeutics

Biotech·UK·Exited 2021·Held 2yr

Gyroscope Therapeutics is a biotech company, headquartered in UK.

Entry
2019
Hold
2yr
Exit
2021
Est. EV
–

Who owns Gyroscope Therapeutics?

Gyroscope Therapeutics was owned by Cambridge Innovation Capital through CIC Fund I (2013 vintage) from 2019 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-29

Cambridge Innovation Capital
Investor
Cambridge Innovation Capital
CIC Fund I · 2013 · VC

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from CIC Fund I

Other portfolio companies in the same fund.

Audio Analytic
Exited 2022
AI/MLUK· 2017
to
Cytora
Active
InsurTechUK· 2017
Riverlane
Active
Deep TechUK· 2017
Bicycle Therapeutics
Active
BiotechUK· 2016
CMR Surgical
Active
MedTechUK· 2016
Inivata
Exited 2021
HealthTechUK· 2016
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings